Skip to main content
Skip to navigation
Print subscriptions
Sign in
Search jobs
Search
International edition
International edition
UK edition
US edition
Australia edition
Europe edition
The Guardian - Back to home
The Guardian
News
Opinion
Sport
Culture
Lifestyle
Show
More
Show More
News
View all News
World news
UK news
Climate crisis
Ukraine
Environment
Science
Global development
Football
Tech
Business
Obituaries
Opinion
View all Opinion
The Guardian view
Columnists
Cartoons
Opinion videos
Letters
Sport
View all Sport
Olympics 2024
Football
Cricket
Rugby union
Tennis
Cycling
F1
Golf
US sports
Culture
View all Culture
Books
Music
TV & radio
Art & design
Film
Games
Classical
Stage
Lifestyle
View all Lifestyle
Fashion
Food
Recipes
Love & sex
Health & fitness
Home & garden
Women
Men
Family
Travel
Money
Search input
google-search
Search
Support us
Print subscriptions
International edition
UK edition
US edition
Australia edition
Europe edition
Search jobs
Holidays
Digital Archive
Guardian Licensing
About Us
The Guardian app
Video
Podcasts
Pictures
Newsletters
Today's paper
Inside the Guardian
The Observer
Guardian Weekly
Crosswords
Wordiply
Corrections
Search jobs
Holidays
Digital Archive
Guardian Licensing
About Us
GlaxoSmithKline
July 2024
Nils Pratley on finance
GSK’s health is improving. Shame about the legal heartburn
Nils Pratley
Emma Walmsley’s overhaul seems to be delivering the goods even if US worries have left the share price becalmed
March 2024
GlaxoSmithKline boss’s pay package jumps 50% to £12.7m
Emma Walmsley’s deal, with a high share bonus payout, makes her one of top-paid CEOs in FTSE 100
September 2023
People with HIV offered hope of self-injected drug at home
GSK-controlled company works on developing patient-administered treatment by end of the decade
August 2023
FTSE 100 bosses ‘given average pay rise of £500,000 in 2022’
CEOs received average increase of 16% while pay of many working for them failed to keep up with inflation
July 2023
RSV vaccine for older adults approved by UK medicines regulator
Arexvy could help NHS deal with virus that causes about 8,000 deaths among older people in UK each year
June 2023
Fair Access
‘Gamechanging’ TB vaccine within reach after $500m pledge to run final trials
Joint deal between Gates Foundation and Wellcome to develop M72 jab could save 8.5 million lives and prevent 76 million cases
April 2023
New CBI boss says she is ‘profoundly sorry’ to women let down by group
AstraZeneca overtakes Pfizer as crunch week for UK pharma looms
February 2023
Nils Pratley on finance
Take AstraZeneca’s warning seriously. The UK is missing out in life sciences
Nils Pratley
GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D pledge
December 2022
Nils Pratley on finance
Moonpig flotation price, like so many, was always pie-in-the-sky thinking
Nils Pratley
GSK shares surge as US judge dismisses Zantac cancer claims
November 2022
Nils Pratley on finance
Mark Zuckerberg’s metaverse is a joke not shared by investors
Nils Pratley
Meta’s share price is down 73% in 2022 but Facebook investors can’t force the boss to change course
October 2022
‘A better partner’: Labour woos big business in bid to oust Rishi Sunak
Wes Streeting and Jonathan Reynolds test water with pharma firm GSK as party prepares for election
September 2022
Nils Pratley on finance
The only party not getting heartburn over GSK demerger is the lawyers
Nils Pratley
The depressing outcome of the split is a legal challenge in the US over Zantac that will run on for years
July 2022
Nils Pratley on finance
Haleon’s debut suggests it may not be the jewel in GSK’s medicine cabinet
Nils Pratley
Consumer goods spin-off makes few waves in biggest European listing for more than a decade
GSK spin-off Haleon begins trading in biggest European listing in a decade
Consumer health company ends first day on London Stock Exchange with £28.5bn market valuation
London stock market listing of up to £45bn looms as GSK investors vote for demerger
UK pharmaceutical firm to spin off Haleon – which will include brands such as Sensodyne and Panadol – in largest listing since 2011
May 2022
Hundreds of organisations breached patient data rules, reveals BMJ
Boots, Superdrug and other chemists report hay fever pill shortages
About 945 results for GlaxoSmithKline
1
2
3
4
...
Explore more on these topics
Pharmaceuticals industry
Health
Stock markets
FTSE
AstraZeneca